We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+11.01%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$380M
AUM Growth
+$51.2M
Cap. Flow
+$18.7M
Cap. Flow %
4.92%
Top 10 Hldgs %
38.28%
Holding
210
New
18
Increased
73
Reduced
84
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.91M
2
ABT icon
Abbott
ABT
+$7.76M
3
BND icon
Vanguard Total Bond Market
BND
+$1.35M
4
OGN icon
Organon & Co
OGN
+$938K
5
V icon
Visa
V
+$610K

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$1.16M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$665K
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$620K
4
VPL icon
Vanguard FTSE Pacific ETF
VPL
+$599K
5
BABA icon
Alibaba
BABA
+$439K

Sector Composition

Rank Sector Weight
1 Healthcare 25.08%
2 Technology 16.71%
3 Financials 10.29%
4 Industrials 9.17%
5 Communication Services 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIP icon
151
iShares TIPS Bond ETF
TIP
$14.5B
$339K 0.09%
2,625
-65
-2% -$8.38K
CHKP icon
152
Check Point Software Technologies
CHKP
$13B
$333K 0.09%
2,856
+322
+13% +$37.3K
IWF icon
153
iShares Russell 1000 Growth ETF
IWF
$121B
$329K 0.09%
4,304
– –
QQQ icon
154
Invesco QQQ Trust
QQQ
$453B
$327K 0.09%
821
+190
+30% +$73.4K
VNQ icon
155
Vanguard Real Estate ETF
VNQ
$39.2B
$316K 0.08%
2,725
+100
+4% +$10.9K
GS icon
156
Goldman Sachs
GS
$300B
$315K 0.08%
823
– –
NVO
157
Novo Nordisk
NVO
$208B
$314K 0.08%
5,604
– –
NEM icon
158
Newmont
NEM
$98.7B
$310K 0.08%
4,992
– –
CB icon
159
Chubb
CB
$135B
$305K 0.08%
1,576
-4
-0.3% -$751
AB icon
160
AllianceBernstein
AB
$3.43B
$286K 0.08%
5,850
– –
CERN
161
DELISTED
Cerner Corp
CERN
$284K 0.07%
3,059
-15,242
-83% -$1.16M
DMO
162
Western Asset Mortgage Opportunity Fund
DMO
$118M
$282K 0.07%
18,518
– –
IEMG icon
163
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$282K 0.07%
4,713
-204
-4% -$12.6K
EMF
164
Templeton Emerging Markets Fund
EMF
$317M
$280K 0.07%
17,450
+5,100
+41% +$86.9K
PCH
165
DELISTED
PotlatchDeltic
PCH
$280K 0.07%
4,645
-135
-3% -$7.57K
NFLX icon
166
Netflix
NFLX
$299B
$278K 0.07%
4,610
– –
NTR icon
167
Nutrien
NTR
$33.2B
$271K 0.07%
3,606
-135
-4% -$9.45K
ELV icon
168
Elevance Health
ELV
$81.5B
$267K 0.07%
575
– –
SLYV icon
169
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$266K 0.07%
+3,135
New +$268K
CMP icon
170
Compass Minerals
CMP
$1.23B
$264K 0.07%
5,170
+340
+7% +$20.7K
CLX icon
171
Clorox
CLX
$11.6B
$263K 0.07%
1,506
+35
+2% +$5.83K
D icon
172
Dominion Energy
D
$60.8B
$259K 0.07%
3,303
– –
MCD icon
173
McDonald's
MCD
$192B
$256K 0.07%
954
-10
-1% -$2.52K
DEO icon
174
Diageo
DEO
$49B
$252K 0.07%
1,145
– –
VYM icon
175
Vanguard High Dividend Yield ETF
VYM
$80.9B
$251K 0.07%
2,243
– –
5 6
7
8 9

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Roberts, Glore & Co held 210 positions worth $380M, up 16% from $329M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Roberts, Glore & Co deployed $18.7M of net new capital in Q4 2021, opening 18 new positions and adding to 73 existing holdings. Its largest new stake was Organon & Co: 28,791 shares worth $877K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cerner Corp, an estimated $1.16M trimmed.

  • Roberts, Glore & Co's largest Q4 2021 buy was Organon & Co: 28,791 shares worth $877K.
  • Roberts, Glore & Co added most to AbbVie in Q4 2021, an estimated $7.91M increase.
  • Roberts, Glore & Co's biggest Q4 2021 reduction was Cerner Corp, cutting an estimated $1.16M.
  • Roberts, Glore & Co fully exited Dell in Q4 2021, selling an estimated $298K.
  • Roberts, Glore & Co's ten largest holdings make up 38% of its $380M portfolio in Q4 2021.
  • Roberts, Glore & Co opened 18 new positions and closed 3 in Q4 2021.
  • Roberts, Glore & Co's portfolio value rose 16% quarter-over-quarter to $380M.

Based on Roberts, Glore & Co's 13F filing for Q4 2021, filed 11 Feb 2022.